{
  "info": {
    "company_name": "EXACT Sciences Corp.",
    "company_url": "https://www.responsibilityreports.com/Company/exact-sciences-corp",
    "ticker_name": "EXAS",
    "exchange": "NASDAQ",
    "industry": "Biotechnology",
    "sector": "Healthcare",
    "about_company": "Exact Sciences Corporation, a molecular diagnostics company, focuses on developing a molecular diagnostic screening technology for the early detection and prevention of colorectal pre-cancer and cancer. The company develops Cologuard, a stool-based DNA colorectal cancer screening test that is designed to detect each of the four stages of colorectal cancer, as well as pre-cancerous lesions.",
    "num_employees": "1001-5000 Employees",
    "location": "Based in Madison, Wisconsin"
  },
  "reports": [
    {
      "pdf_url": "https://www.responsibilityreports.com/HostedData/ResponsibilityReportArchive/e/NASDAQ_EXAS_2019.pdf",
      "report_name": "NASDAQ_EXAS_2019"
    },
    {
      "pdf_url": "https://www.responsibilityreports.com/HostedData/ResponsibilityReportArchive/e/NASDAQ_EXAS_2020.pdf",
      "report_name": "NASDAQ_EXAS_2020"
    },
    {
      "pdf_url": "https://www.responsibilityreports.com/HostedData/ResponsibilityReports/PDF/NASDAQ_EXAS_2021.pdf",
      "report_name": "NASDAQ_EXAS_2021"
    }
  ]
}